Literature DB >> 2253341

The unique lipoprotein(a): properties and immunochemical measurement.

J J Albers1, S M Marcovina, M S Lodge.   

Abstract

Lipoprotein (a) [Lp(a)] represents a class of lipoprotein particles defined by the presence of apolipoprotein(a), a unique glycoprotein linked by a disulfide bond to apolipoprotein B-100 to form a single macromolecule. Apolipoprotein(a) is formed by three different structural domains having high amino acid sequence homology with plasminogen. One of the domains, called kringle 4, is present in multiple copies, the number of which varies and is genetically determined. This accounts for the size heterogeneity of apolipoprotein(a) and thus of Lp(a). Because high concentrations of Lp(a) are associated with atherosclerotic cardiovascular and cerebrovascular disease and may inhibit fibrinolysis, interest in measuring Lp(a) has increased considerably, leading to a rapid development of commercially available immunoassays for the measurement of Lp(a) in human plasma. However, the immunochemical measurement of Lp(a) has several peculiar problems in addition to those encountered by the measurements of other apolipoproteins. The major problems that need to be carefully evaluated are (a) the structural complexity and heterogeneity of Lp(a), (b) the homology of apolipoprotein(a) with plasminogen, (c) the lack of standardization of the methods, and (d) the lack of a common means of expressing the Lp(a) values.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253341

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

Review 1.  Lipoprotein(a): implications for clinical practice.

Authors:  Robert C Block; Thomas A Pearson
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

2.  The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans.

Authors:  V Mooser; D Scheer; S M Marcovina; J Wang; R Guerra; J Cohen; H H Hobbs
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

3.  Lipoprotein(a)

Authors:  J Scott
Journal:  BMJ       Date:  1991-09-21

4.  Lipoprotein(a) is related to the extent of lesions in the coronary vasculature and to unstable coronary syndromes.

Authors:  J D Zampoulakis; A A Kyriakousi; K A Poralis; N T Karaminas; I D Palermos; E T Chimonas; D V Cokkinos
Journal:  Clin Cardiol       Date:  2000-12       Impact factor: 2.882

Review 5.  Effects of exercise on lipoprotein(a).

Authors:  L T Mackinnon; L M Hubinger
Journal:  Sports Med       Date:  1999-07       Impact factor: 11.136

6.  Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus.

Authors:  A Gaw; E Boerwinkle; J C Cohen; H H Hobbs
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

7.  Immunohistochemical distribution of lipoprotein epitopes in xanthomata from patients with familial hypercholesterolemia.

Authors:  N Sugiyama; S Marcovina; A M Gown; H Seftel; B Joffe; A Chait
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

8.  Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels.

Authors:  J C Cohen; G Chiesa; H H Hobbs
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a).

Authors:  V Mooser; M C Seabra; M Abedin; K T Landschulz; S Marcovina; H H Hobbs
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

10.  Serum lipoprotein(a) concentrations are related to coronary disease progression without new myocardial infarction.

Authors:  A Tamura; T Watanabe; Y Mikuriya; M Nasu
Journal:  Br Heart J       Date:  1995-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.